Literature DB >> 11501581

It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment.

M H Barcellos-Hoff1.   

Abstract

How do normal tissues limit the development of cancer? This review discusses the evidence that normal cells effectively restrict malignant behavior, and that such tissue forces must be subjugated to establish a tumor. The action of ionizing radiation will be specifically discussed regarding the disruption of the microenvironment that promotes the transition from preneoplastic to neoplastic growth. Unlike the highly unpredictable nature of genetic mutations, the response of normal cells to radiation damage follows an epigenetic program similar to wound healing and other damage responses. Our hypothesis is that the persistent disruption of the microenvironment in irradiated tissue compromises its ability to suppress carcinogenesis.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Year:  2001        PMID: 11501581     DOI: 10.1023/a:1011317009329

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  83 in total

Review 1.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

2.  Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.

Authors:  A Glick; N Popescu; V Alexander; H Ueno; E Bottinger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease.

Authors:  S L Schor; A M Schor; A Howell; D Crowther
Journal:  Exp Cell Biol       Date:  1987

4.  Persistence of responsiveness of adult mouse mammary gland to induction by embryonic mesenchyme.

Authors:  T Sakakura; Y Sakagami; Y Nishizuka
Journal:  Dev Biol       Date:  1979-10       Impact factor: 3.582

5.  Skin wound healing: transforming growth factor beta antagonists decrease scarring and improve quality.

Authors:  M W Ferguson
Journal:  J Interferon Res       Date:  1994-10

6.  Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.

Authors:  A B Glick; W C Weinberg; I H Wu; W Quan; S H Yuspa
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

7.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.

Authors:  M H Sieweke; N L Thompson; M B Sporn; M J Bissell
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

Review 8.  Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.

Authors:  T M Fynan; M Reiss
Journal:  Crit Rev Oncog       Date:  1993

9.  Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.

Authors:  R Bhatia; J B McCarthy; C M Verfaillie
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

10.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  36 in total

1.  Fractal analysis in a systems biology approach to cancer.

Authors:  M Bizzarri; A Giuliani; A Cucina; F D'Anselmi; A M Soto; C Sonnenschein
Journal:  Semin Cancer Biol       Date:  2011-04-13       Impact factor: 15.707

2.  Mechanistic modelling suggests that the size of preneoplastic lesions is limited by intercellular induction of apoptosis in oncogenically transformed cells.

Authors:  Pavel Kundrát; Georg Bauer; Peter Jacob; Werner Friedland
Journal:  Carcinogenesis       Date:  2011-10-31       Impact factor: 4.944

3.  A quantitative study of growth variability of tumour cell clones in vitro.

Authors:  C Tomelleri; E Milotti; C Dalla Pellegrina; O Perbellini; A Del Fabbro; M T Scupoli; R Chignola
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

4.  An in-solution ultrasonication-assisted digestion method for improved extracellular matrix proteome coverage.

Authors:  Kirk C Hansen; Lauren Kiemele; Ori Maller; Jenean O'Brien; Aarthi Shankar; Jaime Fornetti; Pepper Schedin
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

5.  DOE program--developing a scientific basis for responses to low-dose exposures: impact on dose-response relationships.

Authors:  Antone L Brooks; Lezlie Couch
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

6.  Very large amounts of radiation are required to produce cancer.

Authors:  Antone L Brooks; T Edmond Hui; Lezlie A Couch
Journal:  Dose Response       Date:  2007-09-30       Impact factor: 2.658

7.  Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.

Authors:  M Bartova; J Hlavaty; Y Tan; C Singer; K Pohlodek; J Luha; I Walter
Journal:  Clin Exp Metastasis       Date:  2017-06-17       Impact factor: 5.150

Review 8.  Cancer as an emergent phenomenon in systems radiation biology.

Authors:  Mary Helen Barcellos-Hoff
Journal:  Radiat Environ Biophys       Date:  2007-11-20       Impact factor: 1.925

9.  Ionizing radiation induces heritable disruption of epithelial cell interactions.

Authors:  Catherine C Park; Rhonda L Henshall-Powell; Anna C Erickson; Rabih Talhouk; Bahram Parvin; Mina J Bissell; Mary Helen Barcellos-Hoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 10.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.